Stefanski, Tirzepatide Once Weekly for the Treatment of Obesity
Pemvidutide, an investigational GLP-1 and glucagon drug, stands out for preserving muscle unusually well (most of the Amycretin vs Zepbound: Investigational Newcomer vs Proven Option Amycretin and Zepbound represent two ends of the weight-loss drug timeline
R., Lingvay, I., Ldemann, J., Andreassen, C., Navarria, A., & Bain, S
In current study, T-RDN by itself caused significantly greater urine flow, sodium excretion and increased CrCl at baseline in both HF and Sham
Most researchers start at 250 mcg once daily, confirm mcg-per-ml concentration before every draw, and cycle 6-8 weeks on with 4-6 weeks off between rounds for full recovery
Not the same as a rigorous clinical trial of course be we need to start somewhere better than surveys